Pharmacokinetics of tacrolimus: clinically relevant aspects
- 11 November 1999
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (7) , 21-24
- https://doi.org/10.1016/s0041-1345(99)00788-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Low systemic exposure to tacrolimus correlates with acute rejectionTransplantation Proceedings, 1999
- Pharmacokinetics of FK 506 and Mycophenolic Acid After the Administration of a FK 506–Based Regimen in Combination With Mycophenolate Mofetil in Kidney TransplantationTransplantation Proceedings, 1998
- Factors Affecting the Pharmacokinetics of Tacrolimus in the First Year After Renal TransplantationTransplantation Proceedings, 1998
- Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findingsTransplant Immunology, 1997
- MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1Transplantation, 1997
- RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATIONTransplantation, 1996
- Altered patterns of drug metabolism in patients with acquired immunodeficiency syndromeClinical Pharmacology & Therapeutics, 1993